OrthoPreserve Gains Breakthrough Designation for Meniscus Implant

OrthoPreserve Defender Implant

OrthoPreserve was granted both a Breakthrough Device Designation and Total Product Life Cycle Advisory Program (TAP) enrollment from FDA for Defender, a meniscus replacement implant.

The designation covers the use of the therapeutic medical device to treat patients who continue to experience knee pain or impairment following a meniscus...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0